Research Article
Framingham Risk Stratification of Middle-Aged Migraineurs
Table 2
Comparison of migraine patients with and without aura.
| | Migraine without aura | Migraine with aura | values |
| Study population | 173 | 48 | n.a. | Mean age | years | years | 0.005 | Males | 59 (34.1%) | 1 (2%) | <0.001 | Females | 114 (65.9%) | 47 (98%) | <0.001 | Smoking | 48 (27.7%) | 12 (25%) | 0.14 | Dyslipidaemia | 31 (18%) | 9 (18.7%) | 0.89 | Hypertension | 92 (53.2%) | 36 (75%) | 0.006 | Diabetes | 20 (11.6%) | 12 (25%) | 0.019 | ACE inhibitors | 56 (32.3%) | 24 (50%) | 0.024 | ARBs | 20 (11.6%) | 8 (16.7%) | 0.34 | Statins | 36 (20.1%) | 4 (8.3%) | 0.04 | Beta-blockers | 48 (27.7%) | 20 (41.7%) | 0.06 | Blood pressure (Hgmm) | 137/84 | 138/82 | 0.23 | Cholesterol (mmol/l) | 5.21 | 5.77 | 0.02 | LDL (mmol/l) | 3.13 | 3.1 | 0.83 | GFR (ml/min) | 73.95 | 74 | 0.77 |
|
|
(ACE inhibitors: angiotensin-converting-enzyme inhibitors; ARBs: angiotensin receptor blockers; LDL: low-density lipoprotein; GFR: glomerular filtration rate).
|